Considering the potential for therapeutic development of (in)GSH, the established safety and tolerability data, biological plausibility, and pilot level clinical evidence of benefit are further supported with this demonstration that (in)GSH is able to augment brain GSH levels
Cell culture studies demonstrate increased expression of synaptic proteins including PSD-95, synaptophysin, and synapsin following Dihexa treatment, confirming molecular mechanisms underlying the observed synaptogenic effects
Vegetarian formula
Dexamethasone - Cyclodextrin- Polymer Co-complexes in aqueous eye drops aqueous humor pharmacokinetics in humans
Consult your doctor if you notice any unusual symptoms after treatment
GSTM1, GSTP1, prenatal smoke exposure, and atopic dermatitis